Comparative in vitro activities of LY191145, a new glycopeptide, and vancomycin against Staphylococcus aureus and Staphylococcus-infected fibrin clots.

Bactericidal activities of LY191145, an investigational glycopeptide, and vancomycin against Staphylococcus aureus were evaluated. Only LY191145 at a concentration 16-fold greater than the MIC was able to achieve 99.9% killing against methicillin-susceptible S. aureus (ATCC 25923; 8.0 h). Both agent...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Kang, S L, Rybak, M J
Materialtyp: Artigo
Språk:Inglês
Publicerad: 1995
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC163044/
https://ncbi.nlm.nih.gov/pubmed/8593034
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk